Porcine Reproductive and Respiratory Syndrome: Key Insights

Porcine reproductive and respiratory syndrome (PRRS) is one of the most economically devastating diseases in the global swine industry, costing U.S. pork producers alone roughly $1.2 billion per year in lost productivity.¹ The disease emerged seemingly out of nowhere in the late 1980s, swept through North America and Europe, and has resisted every attempt at eradication since. What makes PRRS so persistent is a virus that mutates rapidly, hides inside the immune cells meant to destroy it, and can linger silently in carrier animals for months.

Where PRRS Came From

PRRS first appeared as a mystery illness in the midwestern United States around 1987, characterized by waves of late-term abortions in sow herds and severe pneumonia in young pigs. Within a few years, nearly identical outbreaks struck central Europe. The causative virus was identified independently on both continents by the early 1990s.² Since then PRRS has spread worldwide and is now considered endemic in most major pork-producing regions. The virus belongs to the order Nidovirales and was eventually classified into two distinct species: PRRSV-1 (historically called the European type) and PRRSV-2 (the North American type). Despite causing the same disease, the two species share only about 60 percent of their genetic sequence, a gap wide enough that immunity to one offers limited cross-protection against the other.

How the Virus Gets Inside Cells

PRRS virus has a narrow appetite for one specific type of immune cell: the macrophage. Macrophages are the cells that normally patrol tissue, engulfing and destroying invaders. The virus hijacks them by latching onto receptors on their surface. A protein called CD163 is the core receptor that determines whether a cell is susceptible to infection.³ Another surface protein, sialoadhesin, plays a supporting role: it helps pull the virus into the cell efficiently. When both receptors are present, virus production jumps dramatically compared to cells expressing only CD163.⁴

This tight dependence on macrophages shapes everything about the disease. By targeting the very cells responsible for immune defense, the virus essentially hollows out a key part of the pig’s frontline immunity. That is why secondary bacterial infections are so common in PRRS-affected herds: the immune cells that would ordinarily clean up opportunistic bacteria are busy being destroyed by the virus.

What the Disease Looks Like in Sows

The “reproductive” half of the disease name refers to what happens in pregnant sows. Infection during the last third of pregnancy is the most damaging. The virus crosses from the sow’s bloodstream into the uterus, replicates in the endometrium and placenta, and from there reaches the fetuses.⁵ The result is premature farrowing of litters that include stillborn, mummified, and weak-born piglets.⁶ A naive sow herd experiencing its first outbreak can lose a staggering proportion of a farrowing group in this way, with reproductive failure rates that overwhelm normal production planning.

Virus replication in placental tissue appears to be a direct cause of fetal death, not merely a side effect of the sow being sick.⁵ Sows themselves often show milder clinical signs: fever, loss of appetite, and sometimes a bluish discoloration of the ears (the disease was originally nicknamed “blue-ear disease” in Europe). But the real damage is measured in lost piglets.

What the Disease Looks Like in Growing Pigs

In nursery and growing pigs, the respiratory side of PRRS dominates. The hallmark lesion is interstitial pneumonia, where the walls between air sacs in the lung become thickened and inflamed. More severe forms, particularly those triggered by highly virulent strains, can progress to suppurative bronchopneumonia or even tissue death within the lung.⁷ Clinically, affected pigs show labored breathing, coughing, reduced feed intake, and poor growth rates. In young piglets, mortality can be substantial.

The economic toll in the growing phase actually exceeds the breeding-herd losses. In a recent analysis of U.S. production from 2016 to 2020, the growing phase accounted for about $819 million of the annual $1.2 billion total, roughly twice the losses attributed to the breeding phase.¹ That is because the virus does not just kill pigs outright; it slows growth, worsens feed efficiency, and opens the door to secondary infections that require treatment. Much of the cost is hidden in reduced performance rather than dramatic mortality events.

How PRRS Virus Spreads

The virus moves between pigs through direct nose-to-nose contact, semen, and contaminated needles or equipment. It also spreads from sow to fetus across the placenta.⁶ But the transmission route that gives biosecurity planners the most trouble is aerosol spread. Early research suggested airborne transmission between farms was unlikely, but the weight of evidence has shifted. Most current data suggest that aerosol transmission can be the single most important contamination source, with the virus apparently capable of traveling several kilometers under favorable conditions.⁸

On top of airborne routes, the virus can hitch rides on contaminated surfaces, boots, clothing, and equipment. Environmental sampling has confirmed PRRSV contamination on surfaces both inside and outside pig barns that farm personnel frequently touch.⁹ These indirect routes mean that even farms with no direct pig-to-pig contact with infected herds can still be at risk, especially in dense production regions where many farms share roads, personnel, and supply chains.

Why the Virus Is So Hard to Eliminate

Three features of PRRS virus make it exceptionally difficult to stamp out once it enters a herd or region: immune evasion, persistent infection, and rapid genetic change.

The virus has evolved a toolkit for ducking the pig’s immune response. It suppresses both innate defenses (the fast, nonspecific arm of immunity) and adaptive responses (the slower, targeted arm that generates antibodies and memory cells). It also manipulates host cell death pathways and hijacks small regulatory molecules within cells.¹⁰ The practical result is that infected pigs mount a sluggish, delayed antibody response. Neutralizing antibodies, the kind that actually block infection, may not appear until weeks after the virus has already replicated widely and spread to other animals.

While the immune system dithers, the virus establishes long-term residence. Pigs that survive initial infection often become carriers. In one study, virus was recovered from the tonsils and lymph nodes of congenitally infected pigs months after birth, even though no virus could be found in lung tissue or other organs.¹¹ Separately, research on experimentally infected pigs found that roughly 84 percent still harbored virus between 63 and 105 days after exposure, including more than 90 percent of those tested at day 105.¹² These carrier animals appear healthy and shed virus intermittently, making them invisible sources of new outbreaks.

Meanwhile, the virus’s RNA genome mutates constantly and recombines readily. When two different strains co-infect the same pig, their genomes can swap segments to produce novel recombinant viruses. Troublingly, some recombinant strains have shown higher virulence than either parent strain.¹³ Recombination between vaccine-derived and field strains has also been documented, raising the uncomfortable possibility that widespread vaccination itself can contribute to viral diversity.¹⁴

Detecting the Virus in Herds

Because carrier pigs look healthy and individual blood tests can miss low-level shedding, the industry has moved toward population-level surveillance tools. One of the more practical advances has been the use of oral fluid sampling. Instead of drawing blood from individual sows (which is labor-intensive and stressful for the animals), veterinarians hang cotton ropes in farrowing crates that piglets and sows chew on. The collected saliva is pooled and tested by sensitive molecular methods.

This approach has proven surprisingly effective. In one study, all sow blood samples tested negative for PRRSV, but oral fluid samples from pre-weaning litters flagged active wild-type virus circulation. Genetic sequencing of the positive samples confirmed it was field virus, not vaccine strain.¹⁵ Family oral fluids collected from entire litters have been shown to work well for herd-level detection, especially when combined with risk-based targeting of litters most likely to be positive.¹⁶ For producers managing large sow herds, this kind of monitoring is cheaper and less disruptive than bleeding pigs, and it catches infections that individual blood tests miss.

Vaccination and Its Limits

Most PRRS vaccines currently on the market are modified live virus (MLV) vaccines, meaning they contain a weakened but still-living version of the virus. These vaccines reduce clinical disease and improve herd performance, but their track record is inconsistent. Protection depends heavily on how closely the vaccine strain matches the field virus circulating in a given herd, and because the virus changes so quickly, a vaccine that works well against one outbreak may offer little help against the next.¹⁷

There is also a safety concern: the live vaccine virus replicates in the pig, can spread to unvaccinated animals, and can potentially recombine with field strains. Cases of vaccine-derived viruses regaining virulence through recombination have been documented.¹³ Killed-virus vaccines avoid this problem but tend to generate weaker immune responses, leaving producers in a difficult tradeoff between efficacy and safety. New vaccine platforms using subunit proteins, DNA, and viral vectors are under development, but none has yet delivered the broad, reliable protection the industry needs.

Biosecurity and Air Filtration

Given the limits of vaccination, biosecurity remains a critical line of defense. Standard measures include controlling visitor and vehicle access, showering in and out of barns, using dedicated clothing and boots, quarantining incoming animals, and testing semen. These practices reduce virus introduction through fomites and direct contact. But they do not address airborne spread, which, as noted earlier, can carry the virus over several kilometers.

Air filtration systems have emerged as a practical, if expensive, solution. In a controlled trial, aerosol transmission of PRRSV was observed in six of twenty replicates in a non-filtered facility, while every pig in the filtered facility remained negative.¹⁸ Long-term field data reinforce the point. A 16-year longitudinal study of breeding herds found that filtered farms experienced roughly half the PRRS incidence rate of non-filtered farms. Farms using positive-pressure filtration fared especially well, showing about 0.42 times the incidence rate of unfiltered herds. And the protective effect appeared to grow stronger over time.¹⁹

The downside is cost. Installing and maintaining filtration in large commercial barns requires substantial capital investment, plus ongoing filter replacement and energy expenses. For high-value breeding herds where a single PRRS outbreak can cause six-figure losses, the math often works out. For finishing barns with lower-value animals, the economics are tighter and the decision depends on regional disease pressure.

Natural Genetic Resistance in Different Breeds

Not all pigs respond the same way to PRRS virus. Breed and genetic background significantly influence how sick a pig gets, how much virus it produces, and how quickly it clears the infection.²⁰ Different breeds mount immune responses of varying strength and character, and researchers have identified a range of host genetic factors, from single-letter changes in the DNA to differences in receptor molecules and gut microbiome composition, that help explain the variation.²¹

This variability exists even within commercial breeding lines. There is substantial natural variation in resistance and susceptibility among the genetics already used by the industry.²² That has opened the door to selective breeding programs that aim to improve herd-level resilience without relying solely on vaccination. The challenge is that resistance to PRRS is likely controlled by many genes acting together, making it slow to improve through traditional selection. And selecting too aggressively for disease resistance can come at the cost of growth rate, litter size, or other economically important traits.

Gene-Edited Pigs That Resist the Virus

A more radical approach takes aim at the CD163 receptor itself. If CD163 is the door the virus uses to enter macrophages, gene editing can effectively lock that door. Several research groups have used CRISPR-Cas9 to remove or modify the specific part of the CD163 protein that the virus latches onto: a region encoded by exon 7 of the gene.

The results have been striking. Macrophages from pigs lacking this domain showed complete resistance to both major PRRSV species; confocal imaging confirmed the virus could not even begin its replication cycle inside these cells.²³ In live-animal challenge trials with a highly virulent strain, gene-edited pigs had dramatically reduced viral loads and fever. While all unedited control pigs died, three of four edited pigs survived and recovered.²⁴

A key concern with deleting part of CD163 is that the protein has a normal day job: clearing hemoglobin-haptoglobin complexes from the blood after red blood cells break down. Reassuringly, studies have found that pigs with the modified CD163 gene show no detectable changes in this function, nor in growth rate, health, meat composition, or reproductive ability across multiple generations of breeding.²⁵ The edit is heritable and stable, meaning it passes reliably to offspring without reverting.

The scientific case is strong. The practical and regulatory barriers are another matter. Gene-edited livestock face different regulatory pathways depending on the country, and consumer acceptance of gene editing in food animals remains uncertain in many markets. Whether PRRS-resistant pigs reach commercial farms in the near term will depend as much on politics and trade policy as on biology.

Coordinated Regional Elimination Programs

Because the virus spreads between farms through the air, on trucks, and through shared personnel, no single farm can control PRRS in isolation. This has driven the development of regional control programs in which neighboring producers share diagnostic data and coordinate their biosecurity responses. The idea is straightforward: if every farm in a geographic cluster monitors its PRRS status and follows agreed-upon action plans when an outbreak is detected, the virus can be squeezed out of the region over time.

Earlier versions of these programs were largely voluntary and focused on sharing test results without binding anyone to specific actions. More recent proposals push further, calling for real-time data sharing across multiple platforms, pre-defined response plans that kick in automatically when virus is detected, and coordinated intervention across all participating farms at once.²⁶ The logic is that half-measures allow the virus to persist in holdout herds and reinfect neighbors. Success requires everyone in the region pulling in the same direction, which is a social and economic challenge as much as a veterinary one.

Several regional projects in the United States and Canada have achieved meaningful reductions in PRRS prevalence within their boundaries, though complete elimination has proven elusive in most cases. The programs work best in areas with moderate farm density, strong producer cooperation, and consistent funding for diagnostics. In extremely dense production regions, where farms are packed closely together and aerosol transmission is hard to interrupt, regional elimination is more aspirational than achievable with current tools. That calculus could change if technologies like air filtration and gene-edited resistant pigs become more widely adopted, but for now the fight against PRRS remains a grinding, farm-by-farm, region-by-region effort.